Related Experiment Video
Updated: Jun 13, 2026
09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Single-cell transcriptomic profiling uncovers key molecular signatures in glioma pathogenesis
Chengcong Gu1, Xiaojin Wu2, Liang Yang2
1Department of Emergency, Nanhu District People's Hospital, Jiaxing, Zhejiang, China.
Frontiers in Genetics
|June 12, 2026
Summary
This study used single-cell RNA sequencing to analyze glioma, revealing distinct cell types and molecular signatures. FTH1 and GM42418 were identified as potential biomarkers for glioma, offering new therapeutic targets.
Area of Science:
- Neuro-oncology
- Genomics
- Translational Medicine
Background:
- Glioma is a prevalent and lethal central nervous system tumor with significant cellular heterogeneity.
- Understanding glioma at single-cell resolution is crucial for developing effective therapies and improving patient outcomes.
Purpose of the Study:
- To comprehensively characterize glioma at the single-cell level.
- To identify novel molecular biomarkers and therapeutic targets for glioma.
Main Methods:
- Single-cell RNA sequencing (scRNA-seq) was performed on glioma samples.
- Computational analyses including PCA, UMAP, t-SNE, and differential expression analysis were utilized.
- Gene co-expression networks and pathway enrichment analyses were conducted.
- Candidate biomarkers were validated using qRT-PCR and ELISA.
Main Results:
- High-quality scRNA-seq data yielded 22 distinct cellular clusters.
- Key genes involved in cell cycle regulation, immune response, and neural lineage were identified.
- Seven major cell populations were annotated: astrocytes, oligodendrocytes, microglia, neural stem cells, OPC/immature neurons, pericytes, and T cells.
- Five functional modules were revealed, with hub genes including CLEC12A, CLU, AQP4, and S100A16.
- PLP1 was downregulated, while FTH1 and GM42418 were upregulated in glioma cells.
Conclusions:
- Single-cell transcriptomics effectively characterized glioma cellular heterogeneity.
- FTH1 and GM42418 were validated as potential molecular biomarkers for glioma.
- This study provides novel insights into glioma pathogenesis and identifies potential therapeutic targets.
